Coronary interventions

Adverse events with orbital atherectomy: an analytic review of the MAUDE database

EuroIntervention 2020;16:e325-e327. DOI: 10.4244/EIJ-D-19-00295

Nauman Khalid
Nauman Khalid1, MD; Hasan Javed1, MD; Toby Rogers1, MD, PhD; Hayder Hashim1, MD; Evan Shlofmitz1, DO; Jason P. Wermers1, BSc; Yuefeng Chen1, MD, PhD; Anees Musallam1, MD; Jaffar M. Khan1, BM, BCh; Rebecca Torguson1, MPH; Nelson L. Bernardo1, MD; Ron Waksman1, MD
1. Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA


Coronary artery calcification (CAC) poses a challenge for successful percutaneous coronary intervention. CAC is associated with worse periprocedural and long-term clinical outcomes because of difficult device delivery and inadequate stent expansion. Atherectomy can effectively ablate and modify calcified plaques, optimising procedural outcomes. The Diamondback 360® Coronary Orbital Atherectomy System (Cardiovascular Systems, Inc., St. Paul, MN, USA) is indicated for lesion preparation of de novo severely calcified coronary lesions before stent implantation. Orbital atherectomy (OA) employs an eccentrically mounted 1.25 mm diamond-coated crown that utilises centrifugal force to orbit at either 80,000 or 120,000 rpm. OA has a unique bidirectional mechanism ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Coronary interventionsOther coronary interventions
Read next article
A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis

Latest news